Singclean Medical Is Committed To Caring For The Elderly And Giving Back To The Community
April 21, 2021
Singclean Medical Organized 18th Anniversary Trail Walking to Increase Employees’ Healthcare Awareness
April 21, 2021

Big congrats to Singderm®, a whole new generation dermal filler developed by Singclean Medical, getting CE mark today!
Singderm® project begun in 2013. In 2015, Singclean has built a controllable and adjustable cross-linking technology platform and realized the unique SingLink® patented cross-linking technology through international cooperation and partnerships. In 2018, Singderm® has passed 12-month clinical verification in three tier 3 hospitals in China with high stability, safety and effectiveness while obtaining CFDA certification early this year.
What's Singderm®?
Singderm® is made of cross-linked, non-animal hyaluronic acid obtained by bio-fermentation technology. It is a 24 mg/ml hyaluronic acid-based dermal filler which is mono-phasic and contains 0.3% lidocaine to reduce injection pain.
Intended Use
Singderm® dermal filler is indicated for injection into the mid to deep dermis or subcutaneous for smoothing moderate to severe facial wrinkles and folds, restoring age-related volume loss, as well as improving facial contours, which is more similar to Juvederm_Ultra_Plus_XC.
Specifications
1ml, 2ml, 10ml with 27G/26G needle
How Long Does Singderm® Last?
Typically, the effects can last at least 12 month, but the longevity can also be affected by various factors, like where the filler is used, how much is injected and the individual's metabolic rate.
Before and After Photos
Recommended Areas for Singderm® Injection
HJKCMI@3F]_79PKZMKRQIVT
Clinical Data
Why choose Singderm®?
1. Safe and Reliable
Singderm®, being animal-origin free, is derived from Streptococcus fermentation; and is terminally sterilized by the moist heat method, the product's sterility assurance level is increased from one thousandth to one millionth, product safety is significantly improved; BD HylokTM professional hyaluronic acid syringe with safe and robust needle connection is adopted. Multiple ways ensure the safety of the product, so far no adverse event feedback has been received.
2. Good Biocompatibility
Singderm® is similar to the body's own naturally produced hyaluronic acid with stable structure and high tissue affinity. The osmotic pressure and PH value are close to the human body, greatly reducing the probability of redness and swelling.
3. Soft and Natural
Singderm® is a mono-phase hyaluronic acid, which is a smooth and homogeneous gel, soft in texture without foreign body sensation, creating a more natural look and a major lifting effect.
4. High Viscoelasticity
High viscosity will not be easy for dermal filler to shift and deform; high elasticity can offer strong supporting force with strong ability to resist deformation caused by external force. The perfect combination of viscosity and elasticity can effectively improve uneven skin tone, enhance face shape and bring perfect and natural facelifts.
5. Long-Lasting effect
Stable crosslinking technology and high content of HA play a decisive role in the long-Lasting effect of dermal fillers. According to multi-center clinical verifications, the 6-month and 12-month effectiveness rate of Singderm® reaches 94.0% and 92.7% respectively while currently the highest 12-month effectiveness rate of the internationally well-known dermal filler is 83%.
6. Pleasant and Painless Experience
Singderm® contains 0.3% lidocaine, effectively reducing the pain caused by injection and giving patients better experience of slight pain or even no pain during the injection.
The Market Size of Dermal Filler
It's no doubt that the demand for injectable fillers is on the rise.
According to Grand View Research, the Europe hyaluronic acid based dermal fillers market size was estimated at USD 979.7 million in 2019 and is expected to grow at a compound annual growth rate of 7.6% from 2019 to 2026 to reach USD 1.4 billion by 2026 while single-phase products segment accounted for the largest Europe hyaluronic acid based dermal fillers market share, around 58% share in the market in 2019.
So don’t hesitate, take the chance, get ready to be surprised with our epoch-making Singderm® and work with us to create a successful business partnership!

Leave a Reply

Your email address will not be published. Required fields are marked *